Peregrine Asset Advisers, Inc. Pfizer Inc Transaction History

Peregrine Asset Advisers, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$32.09 - $37.51 $209,290 - $244,640	6,522 New	6,522 $216,000
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $2.21 Million - $2.62 Million	-47,546 Reduced 83.8%	9,190 $482,000
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $2.92 Million - $3.62 Million	-63,841 Reduced 52.95%	56,736 $2.94 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $46,485 - $68,906	1,125 Added 0.94%	120,577 $7.12 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $233,105 - $299,444	5,939 Added 5.23%	119,452 $5.14 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $4,811 - $5,451	-134 Reduced 0.12%	113,513 $4.45 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $141,260 - $159,313	-4,218 Reduced 3.58%	113,647 $4.12 Million
Q4 2020 Feb 04, 2021	SELL	$33.47 - $42.56 $56,095 - $71,330	-1,676 Reduced 1.4%	117,865 $4.34 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $3.02 Million - $3.54 Million	95,114 Added 389.38%	119,541 $4.39 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $538,274 - $653,006	17,871 Added 272.59%	24,427 $799,000
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $177,208 - $253,192	6,556 New	6,556 $214,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Peregrine Asset Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Peregrine Asset Advisers, Inc. with notifications on news.